Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (5,723,856)	$ (5,582,109)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation	94,645	58,329
Stock-based compensation	611,493	529,283
Bad debt expense	26,075	0
Loss on disposal of asset	0	202
Amortization of right-of-use assets	162,638	66,653
Loss on equity investment	33,208	0
Other non-cash charges	69,521	1,772
Changes in operating assets and liabilities:
Accounts receivable	602,033	(194,455)
Inventories	(496,529)	(28,200)
Prepaid expenses and other current assets	345,470	(426,749)
Other assets	(15,704)	0
Accounts payable and accrued expenses	(485,997)	17,926
Operating Lease Liabilities	(195,244)	54,983
Deferred revenue	1,650	(2,512)
Other liabilities	0	(4,637)
Net cash used in operating activities	(4,970,597)	(5,509,514)
CASH FLOWS FROM INVESTING ACTIVITIES
Investment in Jiangxi Myomo Medical Assistive Appliance Co. Ltd.	(199,000)	0
Purchases of equipment	(102,672)	(247,644)
Net cash used in investing activities	(301,672)	(247,644)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from exercise of warrants	0	7,288,275
Proceeds from payments under grants	0	1,208
Net cash provided by financing activities	0	7,289,483
Effect of foreign exchange rate changes on cash	(16,195)	(1,122)
Net (decrease) increase in cash, cash equivalents and restricted cash	(5,288,464)	1,531,203
Cash, cash equivalents and restricted cash, beginning of period	15,524,378	12,241,261
Cash, cash equivalents and restricted cash, end of period	10,235,914	13,772,464
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Right of use assets obtained in exchange for lease liabilities	225,665	654,091
Property and equipment included in accounts payable and in accrued expenses and other liabilities	$ 0	$ 36,102